Engineers Gate Manager LP Repligen Corp Transaction History

Engineers Gate Manager LP

$5.42 Billion
Q4 2024

A detailed history of Engineers Gate Manager LP transactions in Repligen Corp stock. As of the latest transaction made, Engineers Gate Manager LP holds 2,014 shares of RGEN stock, worth $296,319. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,014

Previous 10,446 80.72%

Holding current value

$296,319

Previous $1.55 Million 81.4%

% of portfolio

0.01%

Previous 0.03%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$123.41 - $160.92 $1.04 Million - $1.36 Million	-8,432 Reduced 80.72%	2,014 $289,000
Q3 2024 Nov 14, 2024	SELL	$119.79 - $167.35 $234,788 - $328,006	-1,960 Reduced 15.8%	10,446 $1.55 Million
Q2 2024 Aug 14, 2024	BUY	$120.0 - $182.95 $1.15 Million - $1.75 Million	9,575 Added 338.22%	12,406 $1.56 Million
Q1 2024 May 15, 2024	BUY	$170.78 - $208.42 $483,478 - $590,037	2,831 New	2,831 $520,000
Q2 2023 Aug 14, 2023	SELL	$138.42 - $180.31 $117,103 - $152,542	-846 Reduced 30.15%	1,960 $277,000
Q1 2023 May 15, 2023	BUY	$154.26 - $198.1 $432,853 - $555,868	2,806 New	2,806 $472,000
Q3 2022 Nov 14, 2022	BUY	$160.42 - $256.21 $1.79 Million - $2.86 Million	11,150 New	11,150 $2.09 Million
Q4 2021 Feb 14, 2022	SELL	$247.59 - $304.47 $210,203 - $258,495	-849 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$194.77 - $324.21 $165,359 - $275,254	849 New	849 $245,000
Q2 2021 Aug 16, 2021	SELL	$165.87 - $220.95 $204,849 - $272,873	-1,235 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$180.37 - $226.26 $222,756 - $279,431	1,235 New	1,235 $240,000
Q4 2020 Feb 16, 2021	SELL	$148.08 - $206.57 $2 Million - $2.79 Million	-13,523 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$122.51 - $158.27 $1.66 Million - $2.14 Million	13,523 New	13,523 $2 Million

Others Institutions Holding RGEN

# of Institutions

482

Shares Held

56.3M

Call Options Held

251K

Put Options Held

458K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.16B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Account

Engineers Gate Manager LP Repligen Corp Transaction History